
Lululemon Secures NFL Apparel Deal, TikTok Sale to Be Finalized this Week
The Rundown
00:00
Novartis Acquires Avidity for RNA Therapeutics Exposure
Zaid covers Novartis's $12B all-cash buyout of Avidity, the premium paid, and strategic rationale for RNA-based drug capabilities.
Transcript
Play full episode


